Hepatocellular carcinoma (HCC) has a poor outcome. Most HCCs develop in the context of liver fibrosis and cirrhosis caused by chronic inflammation. Short-term fasting approaches enhance the activity of chemotherapy in preclinical cancer models, other than HCC. Multi-tyrosine kinase inhibitor Sorafenib is the mainstay of treatment in HCC. However, its benefit is frequently short-lived. Whether fasting can alleviate liver fibrosis and whether combining fasting with Sorafenib is beneficial remains unknown. A 24 hr fasting (2% serum, 0.1% glucose)-induced changes on human hepatic stellate cells (HSC) LX-2 proliferation/viability/cell cycle were assessed by MTT and flow cytometry. Expression of lypolysaccharide (LPS)-induced activation markers (vimentin, αSMA) was evaluated by qPCR and immunoblotting. Liver fibrosis and inflammation were evaluated in a mouse model of steatohepatitis exposed to cycles of fasting, by histological and biochemical analyses. A 24 hr fasting-induced changes were also analyzed on the proliferation/viability/glucose uptake of human HCC cells exposed to Sorafenib. An expression panel of genes involved in survival, inflammation, and metabolism was examined by qPCR in HCC cells exposed to fasting and/or Sorafenib. Fasting decreased the proliferation and the activation of HSC. Repeated cycles of short term starvation were safe in mice but did not improve fibrosis. Fasting synergized with Sorafenib in hampering HCC cell growth and glucose uptake. Finally, fasting normalized the expression levels of genes which are commonly altered by Sorafenib in HCC cells. Fasting or fasting-mimicking diet diets should be evaluated in preclinical studies as a mean to potentiate the activity of Sorafenib in clinical use.

Center for Translational Medicine St Anne's University Hospital Brno Czech Republic

Department of Biochemistry Biophysics and General Pathology University of Campania Luigi Vanvitelli Naples Italy

Department of Biology Masaryk University Brno Czech Republic

Department of Experimental Biomedicine and Clinical Neurosciences Section of Human Anatomy University of Palermo Palermo Italy

Department of Medicine Surgery and Neuroscience University of Siena Siena Italy

Department of Microbiology Immunology and Molecular Genetics University of California Los Angeles California

Euro Mediterranean Institute of Science and Technology Palermo Italy

Gastroenterology Unit IRCCS Casa Sollievo della Sofferenza Hospital San Giovanni Rotondo Italy

Institute for Liver and Digestive Health University College London Royal Free Hospital London UK

Sbarro Institute for Cancer Research and Molecular Medicine Center for Biotechnology College of Science and Technology Temple University Philadelphia Pennsylvania

References provided by Crossref.org

Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+FoxP3+ regulatory T cells activation

The Effects of Meal Timing and Frequency, Caloric Restriction, and Fasting on Cardiovascular Health: an Overview